NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
1.590
+0.010 (0.63%)
At close: Jan 28, 2026, 4:00 PM EST
1.590
0.00 (0.00%)
After-hours: Jan 28, 2026, 4:00 PM EST
NEXGEL Revenue
NEXGEL had revenue of $2.93M in the quarter ending September 30, 2025, a decrease of -0.20%. This brings the company's revenue in the last twelve months to $11.67M, up 73.38% year-over-year. In the year 2024, NEXGEL had annual revenue of $8.69M with 112.47% growth.
Revenue (ttm)
$11.67M
Revenue Growth
+73.38%
P/S Ratio
1.03
Revenue / Employee
$614,000
Employees
19
Market Cap
12.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.69M | 4.60M | 112.47% |
| Dec 31, 2023 | 4.09M | 2.04M | 99.66% |
| Dec 31, 2022 | 2.05M | 497.00K | 32.04% |
| Dec 31, 2021 | 1.55M | 877.00K | 130.12% |
| Dec 31, 2020 | 674.00K | -43.00K | -6.00% |
| Dec 31, 2019 | 717.00K | -1.50M | -67.60% |
| Dec 31, 2018 | 2.21M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.37M |
| Retractable Technologies | 37.90M |
| Bionano Genomics | 28.72M |
| Jin Medical International | 22.83M |
| Precision Optics Corporation | 21.58M |
| Nephros | 17.93M |
| Ekso Bionics Holdings | 14.75M |
| Milestone Scientific | 8.93M |
NXGL News
- 6 weeks ago - NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx - GlobeNewsWire
- 2 months ago - NEXGEL, Inc. (NXGL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - NEXGEL Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - NEXGEL to Report Second Quarter 2025 Financial Results on August 12th - GlobeNewsWire
- 6 months ago - NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 7 months ago - NEXGEL and STADA AG Announce Expansion of Partnership for North America - GlobeNewsWire
- 9 months ago - NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript - Seeking Alpha